{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:51:15Z","timestamp":1785336675270,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003042","name":"Else Kroner-Fresenius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology Plus"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jmccpl.2025.100828","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:12:07Z","timestamp":1763763127000},"page":"100828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Persistently increased CaMKII\u03b4 autophosphorylation mediates pathologic SR Ca loss in a murine model of Doxorubicin-induced cardiomyopathy"],"prefix":"10.1016","volume":"15","author":[{"given":"Anna-Lena","family":"Feder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Tarnowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maria","family":"Pf\u00fctzenreuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Johanna","family":"Baier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Mustroph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maithily S.","family":"Nanadikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00f6rthe M.","family":"Katschinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Siegfried","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can Martin","family":"Sag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jmccpl.2025.100828_bb0005","doi-asserted-by":"crossref","DOI":"10.1085\/jgp.202213108","article-title":"Phosphorylation of RyR2 simultaneously expands the dyad and rearranges the tetramers","volume":"156","author":"Asghari","year":"2024","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0010","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0813013106","article-title":"The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload","author":"Backs","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100828_bb0015","doi-asserted-by":"crossref","first-page":"14745","DOI":"10.1038\/s41598-025-98460-8","article-title":"Spectrophotometric and smartphone-based colorimetric methods utilizing polyvinylpyrrolidone-capped silver nanoparticles for determining doxorubicin in human plasma samples","volume":"15","author":"Behboudi","year":"2025","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jmccpl.2025.100828_bb0020","first-page":"207","article-title":"Doxorubicin-induced cardiotoxicity: a comprehensive update","volume":"12","author":"Bhutani","year":"2025","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0025","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaccao.2024.07.016","article-title":"Anthracycline cardiotoxicity in adult Cancer patients: JACC: CardioOncology state-of-the-art review","author":"Camilli","year":"2024","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0035","doi-asserted-by":"crossref","DOI":"10.1172\/JCI37059","article-title":"Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice","author":"Chelu","year":"2009","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.jmccpl.2025.100828_bb0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/proteomes9020027","article-title":"Phosphorylation-dependent interactome of ryanodine receptor type 2 in the heart","volume":"9","author":"Chiang","year":"2021","journal-title":"Proteomes"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.02.019","article-title":"Anthracycline-induced cardiotoxicity - are we about to clear this hurdle?","author":"Dempke","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2008.02.048","article-title":"A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation","author":"Erickson","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0055","article-title":"Isolation of human ventricular cardiomyocytes from Vibratome-cut myocardial slices","volume":"159","author":"Fiegle","year":"2020","journal-title":"J Vis Exp"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0060","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.113.001746","article-title":"Ca2+\/calmodulin-dependent protein kinase II and protein kinase a differentially regulate sarcoplasmic reticulum Ca2+ leak in human cardiac pathology","author":"Fischer","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1379930","article-title":"The inotropic and arrhythmogenic effects of acutely increased late INa are associated with elevated ROS but not oxidation of PKARI\u03b1","author":"Gissibl","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0070","doi-asserted-by":"crossref","DOI":"10.1124\/mol.114.093849","article-title":"Adverse effects of doxorubicin and its metabolic product on cardiac RyR2 and SERCA2A","author":"Hanna","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0075","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021985","article-title":"Enhanced heart failure in redox-dead Cys17Ser PKARI\u03b1 Knock-in mice","author":"Islam","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0080","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175164","article-title":"CRISPR-Cas9 base editing of pathogenic CaMKII\u03b4 improves cardiac function in a humanized mouse model","author":"Lebek","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41514-024-00135-7","article-title":"A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging","author":"Linders","year":"2024","journal-title":"NPJ Aging"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.yjmcc.2018.11.019","article-title":"Progression of excitation-contraction coupling defects in doxorubicin cardiotoxicity","author":"Llach","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0095","article-title":"ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the international cardio-oncology society (IC-OS)","author":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH; ESC Scientific Document Group","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0100","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162891","article-title":"Targeting ryanodine receptors to treat human diseases","author":"Marks","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0105","article-title":"Anthracycline chemotherapy and cardiotoxicity","author":"JV","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0110","article-title":"Concomitant administration of dantrolene is sufficient to protect against doxorubicin-induced cardiomyopathy","author":"Nakamura","year":"2024","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0115","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.109.203836","article-title":"CaMKII-dependent diastolic SR Ca2+ leak and elevated diastolic Ca2+ levels in right atrial myocardium of patients with atrial fibrillation","author":"Neef","year":"2010","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100828_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-023-02010-3","article-title":"Direct regulation of the cardiac ryanodine receptor (RyR2) by O-GlcNAcylation","volume":"22","author":"Okolo","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.yjmcc.2011.07.016","article-title":"CaMKII-dependent SR ca leak contributes to doxorubicin-induced impaired ca handling in isolated cardiac myocytes","author":"Sag","year":"2011","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"10.1016\/j.jmccpl.2025.100828_bb0130","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04715-1","article-title":"WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis","volume":"21","author":"Tai","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0135","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.108.184457","article-title":"Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca2+ leak in chronic heart failure","author":"Terentyev","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215992","article-title":"CaMKII activation participates in doxorubicin cardiotoxicity and is attenuated by moderate GRP78 overexpression","author":"Tscheschner","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.jmccpl.2025.100828_bb0145","article-title":"The emerging role of CaMKII in cancer","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"issue":"22","key":"10.1016\/j.jmccpl.2025.100828_bb0150","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1158\/0008-5472.CAN-10-2664","article-title":"Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy","volume":"70","author":"Zhao","year":"2010","journal-title":"Cancer Res"}],"container-title":["Journal of Molecular and Cellular Cardiology Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772976125005471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772976125005471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:21:15Z","timestamp":1774441275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772976125005471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":30,"alternative-id":["S2772976125005471"],"URL":"https:\/\/doi.org\/10.1016\/j.jmccpl.2025.100828","relation":{},"ISSN":["2772-9761"],"issn-type":[{"value":"2772-9761","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistently increased CaMKII\u03b4 autophosphorylation mediates pathologic SR Ca loss in a murine model of Doxorubicin-induced cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmccpl.2025.100828","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100828"}}